These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12193859)

  • 21. Mount Sinai clinical experience with leucovorin and 5-fluorouracil.
    Bruckner HW
    Adv Exp Med Biol; 1988; 244():157-66. PubMed ID: 3073652
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of advanced pancreatic cancer with multiple liver metastasis that improved remarkably with use of low-dose cisplatin and TS-1].
    Fujito T; Goda F; Matsuyama J; Hojo S; Yano Y; Endo W; Yamazaki K; Maeura Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):293-6. PubMed ID: 12610882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy in advanced pancreatic adenocarcinoma.
    Kollmannsberger C; Peters HD; Fink U
    Cancer Treat Rev; 1998 Apr; 24(2):133-56. PubMed ID: 9728423
    [No Abstract]   [Full Text] [Related]  

  • 24. Advanced pancreatic cancer--5 years on.
    Rao S; Cunningham D
    Ann Oncol; 2002 Aug; 13(8):1165-8. PubMed ID: 12181237
    [No Abstract]   [Full Text] [Related]  

  • 25. Intra-arterial infusion of 5-fluorouracil, leucovorin and cisplatin for primary adenocarcinoma of the urinary bladder.
    Awakura Y; Yamamoto M; Fukuzawa S; Nonomura M; Fukuyama T
    Int J Urol; 1999 Nov; 6(11):581-4. PubMed ID: 10585125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Fazio N; Biffi R; Curigliano G; Lorizzo K; Zampino MG; de Braud F; Chiappa A; Roth A; Goldhirsch A
    J Natl Cancer Inst; 2007 Sep; 99(17):1345-6; author reply 1346-7. PubMed ID: 17728219
    [No Abstract]   [Full Text] [Related]  

  • 27. Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Yu K
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):9-10. PubMed ID: 30807562
    [No Abstract]   [Full Text] [Related]  

  • 28. Perspectives in chemotherapy of pancreatic cancer.
    Klapdor R
    Eur J Surg Oncol; 1991 Apr; 17(2):153-66. PubMed ID: 1707835
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxaliplatin-induced long QT syndrome in a patient with appendiceal adenocarcinoma.
    Woei Chung L; Liao YM; Hsieh CY; Lin CY
    Acta Oncol; 2009; 48(1):156-7. PubMed ID: 18618340
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of pancreatic carcinoma to 5-fluorouracil and leucovorin.
    Grinblatt DL; Benson AB
    Am J Med; 1992 Jan; 92(1):107-9. PubMed ID: 1731500
    [No Abstract]   [Full Text] [Related]  

  • 32. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of gastric cancer with multiple liver metastases responding to combined hepatic arterial and aortic infusion chemotherapy with cisplatinum, 5-fluorouracil, and levofolinate calcium].
    Sugita M; Togo S; Tanaka K; Miura Y; Akiyama H; Nomura M; Kunisaki C; Shimada H
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1835-9. PubMed ID: 12402439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.
    Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; de Chaisemartin C; Giovannini M; Delpero JR
    Oncology; 2009; 76(6):413-9. PubMed ID: 19407474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translating landmark trial-based evidence to the front lines of care for pancreatic cancer: the evolving trial-based and guideline-supported role for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Lima CMSR
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):3-5. PubMed ID: 30807559
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cancer chemotherapy in the future. Discussion].
    Akaza H; Sasaki T; Konishi T; Tsukuda M
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1422-33. PubMed ID: 14594003
    [No Abstract]   [Full Text] [Related]  

  • 37. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
    Milandri C; Calzolari F; Passardi A; Tison C; Giampalma E; Cecconetto L; Golfieri R
    Hepatogastroenterology; 2007 Dec; 54(80):2373-7. PubMed ID: 18265668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete pathologic responses to preoperative chemoradiation in two patients with adenocarcinoma of the pancreas.
    Magnin V; Viret F; Moutardier V; Lelong B; Giovannini M; Monges G; Delpero JR
    Pancreas; 2004 Jan; 28(1):103-4. PubMed ID: 14707739
    [No Abstract]   [Full Text] [Related]  

  • 40. Pancreatic adenocarcinoma responding to cisplatin based cytotoxic chemotherapy.
    Marshall E; Trotter JM; Metcalf C
    Aust N Z J Med; 1991 Oct; 21(5):780-1. PubMed ID: 1722092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.